U.S. C-arms Market Size, Share & COVID-19 Impact Analysis, By Type (Fixed C-arms, Mobile C-arms {Full-Size C-arms, Mini C-arms}), By Application (Orthopedics & Trauma, Cardiology, Neurology, Gastroenterology, Oncology, and Others), By Detector (Flat Panel Detector and Image Intensifier), By End-User (Hospitals, Diagnostic Centers, Specialty Clinics, and Others) and Forecast, 2023-2030

The U.S. C-arms market size was valued at USD 0.91 billion in 2022. The market is projected to grow from USD 0.95 billion in 2023 to USD 1.30 billion by 2030 at a CAGR of 4.6% during the 2023-2030 forecast period.

C-arm is an advanced medical imaging scanner based on X-ray technology. The equipment is primarily used for fluoroscopic imaging during surgical and orthopedic procedures. They are used in various surgical procedures including gastroenterology, urology, and orthopedic.

The rising prevalence of chronic diseases and increasing number of surgical procedures, such as orthopedic, gastroenterology, urology, and others are some of the major factors driving the demand for C-arm machines. The growing preference of the patient population for minimally invasive surgeries over traditional procedures owing to their several benefits is another prominent factor contributing to the U.S. C-arms market growth.

Along with this, the rising focus of the market players on developing and introducing novel imaging technologies to cater to the American population's rising demand is another important factor supporting the market’s progress.

However, the higher cost of C-arm machines, which includes the direct expenses of the equipment, and maintenance cost, among others is expected to limit the adoption of the product. This factor is anticipated to restrain market growth.

COVID-19 IMPACT

Reduced Number of Surgical Procedures amidst Pandemic Restricted Market Growth

The COVID-19 pandemic had a negative impact on the U.S. market. The postponement or cancellation of surgical procedures by patients and healthcare providers was one of the major reasons for decline in the number of surgeries in the country in 2020.

• According to a 2021 article published by Stanford Medicine, there was an overall 10% decline in surgical procedures in 2020 as compared to 2019.

The major players operating in the market reported a decline in their revenues due to disruptions in the supply chain and postponement of the product’s installation in healthcare settings due to the impact of the pandemic.

• For instance, Koninklijke Philips N.V. generated a revenue of USD 3,017 million in 2020 from its image-guided therapy segment and witnessed a decline of around 6.7% in its revenue as compared to 2019.

However, with the lifting of lockdown restrictions in 2021, the number of elective surgical procedures increased in the country owing to the rising number of patient visits to hospitals, outpatient centers, clinics, and other healthcare facilities.

The increased number of surgeries boosted the demand for and installations of these products in various healthcare settings. The key companies reported an increase in their revenues in 2021 as the market recovered from the pandemic.

• According to the 2021 annual report published by Koninklijke Philips N.V., the company generated a revenue of USD 3,186.7 million from its image guided therapy segment and witnessed a growth of around 5.6% as compared to 2020.

Thus, the increasing surgical procedures in the country to treat patients suffering from various chronic conditions and rising adoption of these machines among healthcare providers are expected to augment market growth in the country during the forecast period.

LATEST TRENDS

Integration of Artificial Intelligence in Products by Major Market Players

The increasing research and development activities by major players operating in the market are accelerating technological advancements in C—arms. The integration of Artificial Intelligence (AI) in these products is a key trend seen in the market. Integrating 3D imaging capabilities into C-arm systems is expected to offer several benefits, such as improvement in procedure planning, enhancement in real-time intraoperative guidance, and reduced procedure time, among others.

The increasing focus of key market players on developing and introducing technologically advanced products is expected to fuel the adoption of these products.

• In January 2022, Koninklijke Philips N.V. integrated cloud-based AI and 3D mapping into its mobile C-arm system series, Zenition, to enhance the workflow efficiency.

Thus, the increasing technological advancements and rising penetration of these devices in healthcare facilities are some of the upcoming trends observed in the market.

Request a Free sample to learn more about this report.

DRIVING FACTORS

Several Advantages of FPDs over Traditional X-Ray to Support Product Adoption

C-arms include Flat Panel Detectors (FPDs), which have several benefits when compared to the traditional X-ray film imaging. Some of the major advantages include high sensitivity, short processing time, low geometric distortion, and better image quality. According to a 2022 article by Trivitron Healthcare, the flat-panel technology can provide up to 50% greater field view than a similar class of image intensifier.

The rising focus of key market players on developing and introducing new products with FPD technology is another major factor contributing to the growing adoption of these products.

• For instance, in July 2022, Siemens Healthcare GmbH received the U.S. FDA clearance for its ARTIS icono ceiling with rotational capabilities to carry out a wide range of routine and advanced cardiology and interventional radiology procedures.

The increasing efforts of major players to develop and introduce novel products is one of the key factors anticipated to fuel the U.S. market growth during the forecast period.

RESTRAINING FACTORS

Increasing Use of Refurbished Devices to Restrain Market Growth

The rising demand for C-arm machines among healthcare providers in the country is prompting manufacturers and suppliers to increase their efforts to meet this demand and improve the supply chain. This factor is also increasing the sales of refurbished C-arms by major players in the market to healthcare providers.

The rising use of refurbished products instead of new ones is anticipated to slow market growth. The cost of refurbished products is lower as compared to the new ones.

The increasing number of distributors and suppliers of pre-owned medical devices in the country is another factor contributing to the rising use of refurbished products among healthcare providers.

• For instance, according to a press release by Integrity Medical Systems, Inc., a new C-arm can range around USD 80,000 - 250,000, whereas the refurbished ones range around USD 20,000 - 120,000.

Therefore, the high cost of new products and efficient refurbishment services provided by the major players and suppliers in the country are some of the factors expected to restrain the U.S. C-arms market development.

SEGMENTATION

By Type Analysis

Mobile C-arms Segment Dominated Market Due to its Several Advantages

Based on type, the market is segmented fixed C-arms and mobile C-arms. Mobile C-arms is further segmented into full size and mini C-arms. The mobile C-arms segment dominated the U.S. market share in 2022. The rising use of these devices among healthcare facilities is one of the major reasons for strengthening the segment’s dominance.

The easy movement and positioning of the device, which allows the patient to move around, to get an optimum angle for a high-quality image is one of the prominent advantages of the product, which will increase its adoption. The rising awareness of the advantages of mobile c-arms in trauma and spine & joint surgeries is expanding the use of full-size c-arms in these procedures, thereby accelerating the segment’s growth during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Detector Analysis

Flat Panel Detectors Segment to Gain Traction Owing to Technological Advancements

On the basis of detector, the market is segmented into flat panel detector and image intensifier. The Flat Panel Detector (FPD) segment dominated the market in 2022. Several advantages of these detectors, such as high-resolution images and compact structure, among others, are contributing to the segment's growth. Along with this, rising launch of technologically advanced flat panel detectors is another major factor favoring the growth of the segment.

• For instance, in November 2021, CANON MEDICAL SYSTEMS CORPORATION introduced Hi-Def flat panel detector to help improve a surgeon’s visualization during various interventional radiology, oncology, neurology, and cardiology surgeries.

The image intensifier segment is expected to lose the market share during the forecast period due to its low image quality as compared to the FPD and other limitations.

By Application Analysis

Cardiology Segment Dominates Owing to Rising Number of Cardiac Surgeries

On the basis of application, the market is segmented into orthopedics & trauma, cardiology, neurology, gastroenterology, oncology, and others. The cardiology segment dominated the market share in 2022. The growing prevalence of cardiovascular diseases and rising number of cardiac procedures are a few of the prominent factors increasing the adoption of c-arm machines during cardiac surgeries.

Additionally, rapid technological advancements leading to greater flexibility, efficiency, and increased accuracy of images is another major factor supporting the segment’s growth.

• According to the 2020 data published by the American Heart Association (AHA), the overall prevalence of Cardiovascular Diseases (CVD) was around 48.6% in adults in 2020.

The orthopedics & trauma segment is expected to register the highest CAGR during the forecast period. The rising number of orthopedic surgeries and trauma incidents in the country is expected to boost the adoption of these devices for such procedures.

The neurology segment held the second position in the market in 2022. The rising diagnosis rate of various neurological conditions in the country is responsible for the increasing use of these devices among healthcare providers.

Similarly, the rising technological advancements in these devices, which will increase their efficiency in minimally invasive surgeries is a prominent factor expected to spur the growth of oncology, gastroenterology, and other segments during the forecast period.

By End User Analysis

Hospitals to Increase Reliance on C-Arm Machines Due to Rising Number of Surgeries in These Settings

On the basis of end user, the market is segmented into hospitals, diagnostic centers, specialty clinics, and others. The hospital segment dominated the market in 2022 with the highest share owing to an increasing number of surgical procedures in various areas, such as cardiology and oncology, among others in hospitals.

The diagnostic centers segment is expected to register the highest CAGR during the forecast period. The rising preference among patients for diagnostic centers and specialty clinics to undergo various surgical procedures in the country is one of the major factors contributing to the segment’s growth.

Additionally, the rising collaborations among key players to extend their product portfolios and efficiency of diagnostic procedures in ASCs and clinics is another significant factor supporting the growth of the segment.

• For instance, in April 2022, GE Healthcare and Medtronic collaborated to cater to the rising demand for efficient diagnostic imaging solutions in outpatient care centers.

KEY INDUSTRY PLAYERS

Increasing Product Launches and Focus on Technological Advancements to Foster Key Players’ Market Share

The U.S. market has a consolidated competitive landscape, with few major players accounting for a large proportion of the market.

Siemens Healthcare GmbH, Koninklijke Philips N.V., and GE Healthcare are the key players in the market with a dominating share. The increasing focus of these companies on developing and introducing technologically advanced products to cater to the rising demand among healthcare providers will further help them dominate the market.

The other players include CANON MEDICAL SYSTEMS CORPORATION, Shimadzu Corporation, Hologic Inc., FUJIFILM Corporation, Ziehm Imaging GmbH, and others. These companies are focusing on the development and introduction of new products along with collaborations with other organizations to expand their product portfolios. These factors are anticipated to support their growing shares in the market.

• For instance, in April 2021, Ziehm Imaging GmbH partnered with Carestream Health, a global provider of medical imaging systems, to increase its brand presence and product offerings with the launch of Ziehm Vision RFD C-arm in the U.S. and Canada.

Thus, the rising efforts of the key companies to increase their product’s penetration and market share in the U.S. is expected to boost the growth of the market.

LIST OF KEY COMPANIES PROFILED:

• Siemens Healthcare GmbH (Germany)


• Koninklijke Philips N.V. (Netherlands)


• GE HealthCare (U.S.)


• Shimadzu Corporation (Japan)


• Hologic Inc. (U.S.)


• Ziehm Imaging GmbH (Germany)


• CANON MEDICAL SYSTEMS CORPORATION (Japan)


• Fujifilm Holdings Corporation (Japan)

KEY INDUSTRY DEVELOPMENTS:

• March 2023 - CANON MEDICAL SYSTEMS CORPORATION launched Celex, a multipurpose C-arm system that offers an extensive range of radiographic imaging capabilities with advanced DR technology.


• July 2022 - Ziehm Imaging GmbH presented the highlights of its new product in development, IGZO1 flat-panel detector with Indium Gallium Zinc Oxide (IGZO) technology, which is capable of producing high-resolution images with minimum dose levels.


• November 2021 – Fujifilm Holdings Corporation launched Persona CS mobile C-arm to expand its product portfolio and provide better image guidance in various procedures including orthopedic, trauma surgeries, pain management, and others.


• March 2021 – GE Healthcare received the U.S. FDA 510(k) clearance for its new 3D surgical imaging system, OEC 3D. The system is designed for greater efficiency and precision during surgical procedures.


• January 2021 – Siemens Healthcare GmbH received the U.S. FDA approval for its Cios Flow, mobile C-arm system, designed for use across various applications including orthopedics, trauma surgery, spinal surgery, vascular surgery, and others.

REPORT COVERAGE

The report provides a detailed market analysis. It focuses on key aspects, such as market overview, market segmentation & its analysis, types, detectors, applications, end users, and competitive landscape of the market. Besides this, it offers insights into the market trends and highlights key industry developments. The report further includes analysis of the COVID-19 impact on the market.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation